SkinHealth Systems Inc. (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
10.88
-0.22 (-1.98%)
Oct 23, 2026, 4:00 PM EDT - Market closed
SkinHealth Systems Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 71 | 177 | 197 | 408 | 1,203 | 3,615 | |
Market Cap Growth | -58.03% | -10.20% | -51.66% | -66.07% | -66.72% | 470.81% |
Enterprise Value | 234 | 339 | 407 | 601 | 1,270 | 3,628 |
Last Close Price | 10.88 | 27.80 | 31.80 | 62.20 | 182.00 | 483.20 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 27.21 | - |
Forward PE | 8.74 | 9.12 | 42.50 | 16.31 | 47.05 | 260.64 |
PS Ratio | 0.24 | 0.59 | 0.59 | 1.03 | 3.29 | 13.90 |
PB Ratio | 1.27 | 2.90 | 3.81 | 6.87 | 7.20 | 11.96 |
P/TBV Ratio | - | - | - | - | - | 29.49 |
P/FCF Ratio | 3.35 | 4.77 | 12.83 | - | - | - |
P/OCF Ratio | 3.22 | 4.73 | 12.23 | 18.77 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.81 | 1.13 | 1.22 | 1.51 | 3.47 | 13.95 |
EV/EBITDA Ratio | 11.64 | 74.53 | - | - | - | - |
EV/FCF Ratio | 11.06 | 9.11 | 26.45 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 6.61 | 6.20 | 10.97 | 12.67 | 4.51 | 2.48 |
Debt / EBITDA Ratio | 14.55 | 38.08 | - | - | 370.87 | - |
Debt / FCF Ratio | 17.36 | 10.19 | 36.95 | - | - | - |
Net Debt / Equity Ratio | 2.93 | 2.42 | 3.86 | 3.86 | 1.11 | -0.51 |
Net Debt / EBITDA Ratio | 8.12 | 32.57 | -7.67 | -2.38 | -62.47 | 6.97 |
Net Debt / FCF Ratio | 7.71 | 3.98 | 13.01 | -430.14 | -1.56 | 3.88 |
Asset Turnover | 0.58 | 0.51 | 0.41 | 0.41 | 0.33 | 0.36 |
Inventory Turnover | 1.84 | 1.78 | 1.80 | 2.42 | 1.62 | 2.79 |
Quick Ratio | 1.33 | 1.36 | 5.82 | 5.16 | 9.09 | 12.47 |
Current Ratio | 1.76 | 1.66 | 7.00 | 6.07 | 10.92 | 13.09 |
Return on Equity (ROE) | -43.89% | -16.87% | -52.34% | -88.42% | 18.84% | -278.16% |
Return on Assets (ROA) | -0.54% | -2.19% | -4.63% | -8.47% | -1.45% | -3.46% |
Return on Invested Capital (ROIC) | -1.97% | -9.02% | -22.12% | -40.84% | -10.05% | -23.43% |
Return on Capital Employed (ROCE) | -1.40% | -6.60% | -9.70% | -16.10% | -2.80% | -3.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -40.85% | -5.37% | -14.74% | -24.52% | 3.68% | -10.48% |
FCF Yield | 29.86% | 20.98% | 7.79% | -0.13% | -9.88% | -1.09% |
Buyback Yield / Dilution | -2.43% | 4.70% | -8.21% | 11.33% | -45.43% | -197.77% |